Life sciences briefing: Wednesday, Sept. 12, 2007
Featured companies: Mawell, OpGen, Vital Therapeutics
Optical genome-mapper OpGen raises $23.6M in a restart — OpGen, a Madison, Wisc., biotech developing a genomic test for identifying disease-causing microbes, raised $23.6 million in what the company is billing as a first funding round. In fact, however, the funding is more of a restart for the company, which was founded in 2001 and previously provided genomic services to researchers.
OpGen is now focused on developing speedy genome-based tests that can… Continue Reading
DeviceVM, latest PC virtualization co., raises $10M
DeviceVM is a secretive San Jose start-up founded in August that says it wants to make PC simpler to use with “virtualization” technology.
The co-founders are Mark Lee, Thomas Deng and Robert Ha, the same team that co-founded OSA Technologies, of San Jose, which was sold to Avocent in 2004 for $100 million.
It joins a host of companies entering the virtualization area. Virtualization is a loose term that can applied to a number of technologies. Loosely… Continue Reading